​

Becton, Dickinson and Company (BDX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Becton, Dickinson and Company Revenue Highlights

Latest Revenue (Y)

$21.84B

Latest Revenue (Q)

$5.25B

Main Segment (Y)

Medical

Main Geography (Y)

UNITED STATES

Becton, Dickinson and Company Revenue by Period

Becton, Dickinson and Company Revenue by Year

DateRevenueChange
2025-09-30$21.84B8.23%
2024-09-30$20.18B4.16%
2023-09-30$19.37B2.66%
2022-09-30$18.87B-1.36%
2021-09-30$19.13B19.02%
2020-09-30$16.07B-7.03%
2019-09-30$17.29B8.18%
2018-09-30$15.98B32.17%
2017-09-30$12.09B-3.12%
2016-09-30$12.48B21.41%
2015-09-30$10.28B21.74%
2014-09-30$8.45B4.87%
2013-09-30$8.05B4.49%
2012-09-30$7.71B1.64%
2011-09-30$7.58B6.45%
2010-09-30$7.12B1.97%
2009-09-30$6.99B-1.25%
2008-09-30$7.07B11.25%
2007-09-30$6.36B10.83%
2006-09-30$5.74B5.97%
2005-09-30$5.41B9.73%
2004-09-30$4.93B10.56%
2003-09-30$4.46B12.70%
2002-09-30$3.96B5.49%
2001-09-30$3.75B3.76%
2000-09-30$3.62B5.85%
1999-09-30$3.42B9.67%
1998-09-30$3.12B10.90%
1997-09-30$2.81B1.47%
1996-09-30$2.77B2.11%
1995-09-30$2.71B5.98%
1994-09-30$2.56B3.82%
1993-09-30$2.47B-

Becton, Dickinson and Company generated $21.84B in revenue during NA 2025, up 8.23% compared to the previous quarter, and up 135.87% compared to the same period a year ago.

Becton, Dickinson and Company Revenue by Quarter

DateRevenueChange
2025-12-31$5.25B-10.83%
2025-09-30$5.89B6.92%
2025-06-30$5.51B4.50%
2025-03-31$5.27B2.01%
2024-12-31$5.17B-4.95%
2024-09-30$5.44B8.96%
2024-06-30$4.99B-1.09%
2024-03-31$5.04B7.20%
2023-12-31$4.71B-7.49%
2023-09-30$5.09B4.28%
2023-06-30$4.88B1.18%
2023-03-31$4.82B5.12%
2022-12-31$4.59B-3.68%
2022-09-30$4.76B2.59%
2022-06-30$4.64B-2.29%
2022-03-31$4.75B0.68%
2021-12-31$4.72B-8.12%
2021-09-30$5.13B11.46%
2021-06-30$4.61B-6.11%
2021-03-31$4.91B-7.68%
2020-12-31$5.32B11.10%
2020-09-30$4.78B24.10%
2020-06-30$3.85B-9.36%
2020-03-31$4.25B0.66%
2019-12-31$4.22B-7.83%
2019-09-30$4.58B5.38%
2019-06-30$4.35B3.69%
2019-03-31$4.20B0.84%
2018-12-31$4.16B-5.50%
2018-09-30$4.40B2.90%
2018-06-30$4.28B1.33%
2018-03-31$4.22B37.08%
2017-12-31$3.08B-2.72%
2017-09-30$3.17B4.32%
2017-06-30$3.04B2.22%
2017-03-31$2.97B1.61%
2016-12-31$2.92B-9.56%
2016-09-30$3.23B1.03%
2016-06-30$3.20B4.27%
2016-03-31$3.07B2.71%
2015-12-31$2.99B-2.42%
2015-09-30$3.06B-1.92%
2015-06-30$3.12B52.12%
2015-03-31$2.05B-
2014-12-31$2.05B-6.86%
2014-09-30$2.20B2.09%
2014-06-30$2.16B4.10%
2014-03-31$2.07B2.83%
2013-12-31$2.02B-4.08%
2013-09-30$2.10B2.34%
2013-06-30$2.05B2.61%
2013-03-31$2.00B5.27%
2012-12-31$1.90B-3.40%
2012-09-30$1.97B-0.67%
2012-06-30$1.98B-0.52%
2012-03-31$1.99B5.47%
2011-12-31$1.89B-7.96%
2011-09-30$2.05B1.82%
2011-06-30$2.01B4.79%
2011-03-31$1.92B4.34%
2010-12-31$1.84B6.32%
2010-09-30$1.73B-7.76%
2010-06-30$1.88B1.81%
2010-03-31$1.84B-3.75%
2009-12-31$1.92B1.00%
2009-09-30$1.90B4.26%
2009-06-30$1.82B4.56%
2009-03-31$1.74B0.42%
2008-12-31$1.73B-5.56%
2008-09-30$1.84B-1.71%
2008-06-30$1.87B6.91%
2008-03-31$1.75B-

Becton, Dickinson and Company generated $5.25B in revenue during Q1 2026, up -10.83% compared to the previous quarter, and up 96.60% compared to the same period a year ago.

Becton, Dickinson and Company Revenue Breakdown

Becton, Dickinson and Company Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceSep 25Sep 24Sep 23Sep 22Sep 21
Life Sciences$5.17B$5.19B$2.30B--
Interventional$5.22B$4.98B---
Medical$11.46B$10.07B$2.00B--
Products and/or Services--$2.30B$2.50B$2.10B
Consumables--$2.00B$1.90B$2.50B

Becton, Dickinson and Company's latest annual revenue breakdown by segment (product or service), as of Sep 25: Medical (52.45%), Interventional (23.89%), and Life Sciences (23.66%).

Quarterly Revenue by Product

Product/ServiceDec 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20
Medical$2.40B$2.93B$2.76B$2.62B$5.82B$2.10B$1.11B$1.05B$581.00M$552.00M----------
Life Sciences$2.50B$1.25B$1.25B$1.30B$299.00M$2.30B$1.30B$1.29B$930.00M$1.18B----------
Interventional-$1.33B$1.26B$1.26B$4.04B$489.00M$454.00M$318.00M$306.00M-----------
Products and/or Services-------$2.20B-$2.50B$2.50B$2.50B$2.20B$2.20B$2.10B$1.90B$1.90B$1.90B--
Consumables-------$2.20B-$2.10B$2.20B$1.90B$2.10B$2.40B$2.40B$2.80B$2.70B$2.60B--

Becton, Dickinson and Company's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Life Sciences (51.02%), and Medical (48.98%).

Becton, Dickinson and Company Revenue Breakdown by Country

Annual Revenue by Country

CountrySep 25Sep 24Sep 23Sep 22Sep 21
Asia$3.09B$2.91B$2.91B$3.05B$3.27B
UNITED STATES$12.79B$11.66B$11.11B$10.72B$10.97B
Others Country$1.23B$1.21B$1.10B$1.06B$1.25B
Europe$4.73B$4.40B$4.24B--
EMEA--$4.24B$4.04B$4.75B

Becton, Dickinson and Company's latest annual revenue breakdown by geography, as of Sep 25: UNITED STATES (58.56%), Europe (21.65%), Asia (14.16%), and Others Country (5.62%).

Quarterly Revenue by Country

CountryDec 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20
Non-US$2.09B$2.33B$2.16B$2.09B$2.10B$2.14B$1.96B$2.21B$2.11B$2.09B$1.86B$2.05B$2.00B$2.20B$2.14B$2.33B$2.32B$2.45B$2.19B-
UNITED STATES$3.16B$3.18B$3.11B$3.08B$3.12B$2.89B$2.91B$2.75B$2.88B$2.77B$2.73B$2.73B$2.71B$2.64B$2.81B$2.85B$2.80B$2.57B$2.46B$3.13B

Becton, Dickinson and Company's latest quarterly revenue breakdown by geography, as of Dec 25: UNITED STATES (60.15%), and Non-US (39.85%).

Becton, Dickinson and Company Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CAHCardinal Health$222.58B$65.44B
BDXBecton, Dickinson and$21.84B$5.25B
IQVIQVIA$16.31B$4.10B
HLNHaleon$11.30B$2.92B
ALCAlcon$10.09B$2.46B
AAgilent$6.83B$1.80B
EWEdwards Lifesciences$6.07B$1.55B
RMDResMed$5.15B$1.42B
IDXXIDEXX Laboratories$4.30B$1.11B
VEEVVeeva Systems$2.75B$811.24M
ARGXargenx SE$1.23B$401.00M

BDX Revenue FAQ

What is Becton, Dickinson and Company’s yearly revenue?

Becton, Dickinson and Company's yearly revenue for 2025 was $21.84B, representing an increase of 8.23% compared to 2024. The company's yearly revenue for 2024 was $20.18B, representing an increase of 4.16% compared to 2023. BDX's yearly revenue for 2023 was $19.37B, representing an increase of 2.66% compared to 2022.

What is Becton, Dickinson and Company’s quarterly revenue?

Becton, Dickinson and Company's quarterly revenue for Q1 2026 was $5.25B, a -10.83% decrease from the previous quarter (Q4 2025), and a 1.63% increase year-over-year (Q1 2025). The company's quarterly revenue for Q4 2025 was $5.89B, a 6.92% increase from the previous quarter (Q3 2025), and a 8.33% increase year-over-year (Q4 2024). BDX's quarterly revenue for Q3 2025 was $5.51B, a 4.50% increase from the previous quarter (Q2 2025), and a 10.40% increase year-over-year (Q3 2024).

What is Becton, Dickinson and Company’s revenue growth rate?

Becton, Dickinson and Company's revenue growth rate for the last 3 years (2023-2025) was 12.73%, and for the last 5 years (2021-2025) was 14.16%.

What are Becton, Dickinson and Company’s revenue streams?

Becton, Dickinson and Company's revenue streams in p 25 are Life Sciences, Interventional, and Medical. Life Sciences generated $5.17B in revenue, accounting 23.66% of the company's total revenue, down -0.46% year-over-year. Interventional generated $5.22B in revenue, accounting 23.89% of the company's total revenue, up 4.76% year-over-year. Medical generated $11.46B in revenue, accounting 52.45% of the company's total revenue, up 13.72% year-over-year.

What is Becton, Dickinson and Company’s main source of revenue?

For the fiscal year ending Sep 25, the largest source of revenue of Becton, Dickinson and Company was Medical. This segment made a revenue of $11.46B, representing 52.45% of the company's total revenue.